Regulatory Updates
Sep 22, 2026•1 min read
FDA Approves Multiple Supplemental Applications for Discontinued Chlorothiazide Tablets (ANDA 084217)
The FDA record for ANDA 084217 lists two discontinued oral chlorothiazide tablets (500 mg and 250 mg) and a series of approved supplemental submissions covering manufacturing, labeling and bioequivalence.
Regulatory Updates
Sep 19, 2026•1 min read
FDA Accepts ANDA084026 for Watson Labs' Chlorothiazide 500 mg Oral Tablet (Discontinued)
The FDA has processed application ANDA084026 for Watson Labs' oral chlorothiazide 500 mg tablet, currently listed as discontinued.